Research on Information Used in the Development of Pediatric Drugs in Japan: Utilization of Pharmacokinetic Information-Reference-Cited by-同舟云学术

Research on Information Used in the Development of Pediatric Drugs in Japan: Utilization of Pharmacokinetic Information

Published:2024-01-31 Issue:1 Volume:55 Page:3-10
ISSN:0388-1601
Container-title:Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
language:en
Short-container-title:Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics

Author:

OCHIAI Michiru¹²,MAEDA Mika³⁴,KUWANO Wakana⁵,SUZUKI Mami⁴,ASO Masako⁶,KOBAYASHI Masahiro⁴⁷,OTORI Katsuya⁴⁵,HASUNUMA Tomoko⁸⁹,KUMAGAI Yuji⁸

Affiliation:

1. Kitasato University Graduate School of Medical Sciences, Kanagawa, Japan

2. Department of Pharmacy, Hinatadai Hospital, Kanagawa, Japan

3. Laboratory of Clinical Pharmacoepidemiology and Research and Education Center for Clinical Pharmacy, School of Pharmacy, Kitasato University, Kanagawa, Japan

4. Department of Pharmacy, Kitasato University Hospital, Kanagawa, Japan

5. Laboratory of Pharmacy Practice and Science 1 and Research and Education Center for Clinical Pharmacy, School of Pharmacy, Kitasato University, Kanagawa, Japan

6. Soleil Kawasaki Medical Center for the Handicapped, Kanagawa, Japan

7. Laboratory of Clinical Pharmacokinetics and Research and Education Center for Clinical Pharmacy, School of Pharmacy, Kitasato University, Kanagawa, Japan

8. Department of Research, Kitasato University Kitasato Institute Hospital, Tokyo, Japan

9. Kitasato Clinical Research Center, School of Medicine, Kitasato University, Kanagawa, Japan

Publisher

Japanese Society of Clinical Pharmacology and Therapeutics

Link

https://www.jstage.jst.go.jp/article/jscpt/55/1/55_3/_pdf

Reference20 articles.

1. 1) Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr. 2005; 164（9）: 552-8. doi: 10.1007/s00431-005-1698-8.

2. 2) Richey RH, Shah UU, Peak M, Craig JV, Ford JL, Barker CE, et al. Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence. BMC Pediatr. 2013; 13: 81. doi: 10.1186/1471-2431-13-81.

3. 3) Shirkey H. Therapeutic orphans. J Pediatr. 1968; 72（1）: 119-20. doi: 10.1016/s0022-3476(68)80414-7.

4. 4) Shirkey H. Editorial comment: Therapeutic orphans. Pediatrics. 1999; 104（3 Pt 2）: 583-4.

5. 5) Saitou H, Nakatani D, Myoui A, Kubota T, Ozono K. Pediatric drug development in Japan: Current issues and perspectives. Clin Pediatr Endocrinol. 2020; 29（1）: 1-7. doi: 10.1297/cpe.29.1.